Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study

Date
2017
Author
DOOMS, Christophe
KLEPETKO, Walter
PASSLICK, Bernward
MOLINS, Laureano
RAMI-PORTA, Ramon
THOMAS, Pascal
DE LEYN, Paul
Decaluwe, Herbert
D'JOURNO, Xavier Benoit
CALL, Sergi
SANCHEZ, David
HAAGER, Benedikt
BEELEN, Roel
Kara, Volkan
KLIKOVITS, Thomas
AIGNER, Clemens
TOURNOY, Kurt
ZAHIN, Mahmood
MOONS, Johnny
BRIOUDE, Geoffrey
TRUJILLO, Juan Carlos
Turna, Akif
Metadata
Show full item record
Abstract
A quarter of patients with clinical N1 (cN1) non-small cell lung cancer (NSCLC) based on positron emission tomography-computed tomography (PET-CT) imaging have occult mediastinal nodal involvement (N2 disease). In a prospective study, endosonography alone had an unsatisfactory sensitivity (38%) in detecting N2 disease. The current prospective multicentre trial investigated the sensitivity of preoperative mediastinal staging by video-assisted mediastinoscopy (VAM) or VAM-lymphadenectomy (VAMLA).
URI
http://hdl.handle.net/20.500.12627/46414
https://doi.org/10.1183/13993003.01493-2017
Collections